Health TrialsbyHealthPanel

Healing After Injury to Reduce Opioid Use and Pain Through Preventive Engagement

ConditionsPainOpioid Use
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorHenry Ford Health System

About this trial

The goal of this proposed project is to optimize the adaptive psychological intervention and assess the feasibility and acceptability. The long-term objective of this line of research is to evaluate whether an adaptive psychological intervention delivered after a musculoskeletal injury is effective in preventing the development of chronic pain and long-term opioid use.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Admitted to Henry Ford Hospital

Has an acute musculoskeletal injury

Prescribed opioids during the admission

Disqualifiers

Under age 18

Cognitive impairment (i.e., diagnosis of delirium, dementia, or traumatic brain injury/Glasgow Coma Scale less than 13)

Chronic pain condition (i.e., pain most of the day, nearly every day for the past 3 months or longer)

Taking opioids 30 days or more prior to this hospitalization

Trial design

Design model

Sequential

Treatments tested in this trial

  • Computerized brief intervention

    Behavioral

    Education about long-term opioid use and a mindfulness strategy

  • Psychological sessions

    Behavioral

    Four sessions composed of education, mindfulness, and acceptance-based strategies.

  • Opioid taper recommendations

    Behavioral

    Recommendations will be provided to taper opioid use.

Treatment groups

80 Participants
are divided into 5 treatment groups
Group A: Subgroup 1No intervention 0 interventions
Group B: Subgroup 2Active comparator 1 intervention
Group C: Subgroup 3Experimental treatment 1 intervention
Group D: Subgroup 4Experimental treatment 2 interventions
Group E: Subgroup 5Experimental treatment 3 interventions

Trial outcomes

Primary outcomes

1

Opioid use

Whether patient was using opioids

Time frame
90-day follow-up

Secondary outcomes

1

Morphine Dose Equivalent (MDE)

Dose of opioid use in MDEs

Time frame
90-day follow-up
2

Presence of chronic pain

Whether a patient reports experiencing pain from the injury

Time frame
90-day follow-up
3

Pain severity

On a 0 (no pain) to 10 (worst pain) scale, patients rate their current pain and average, least, and worst pain over the previous week.

Time frame
90-day follow-up
4

Pain interference

Participants report on a 0 (does not interfere) to 10 (completely interferes) scale how much the pain interferes across a variety of daily activities.

Time frame
90-day follow-up

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Henry Ford Health System

Lead sponsor

National Institute on Drug Abuse (NIDA)

Collaborator

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: